Literature DB >> 3288057

Brain ischemia as a target for Ca2+ entry blockers.

A Wauquier1, D Ashton, G H Clincke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3288057     DOI： 10.1111/j.1749-6632.1988.tb33387.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

2.  L-type voltage-dependent calcium channels do not modulate aminergic neurotransmitter release induced by transient global cerebral ischaemia: an in vivo microdialysis study in rat.

Authors:  D Bentué-Ferrer; R Decombe; B Saïag; H Allain; J Van den Driessche
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

3.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 4.  Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 5.  New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.

Authors:  M Bebin; T P Bleck
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.